COSMO Pharmaceuticals N.V. header image

COSMO Pharmaceuticals N.V.

COPN

Equity

ISIN NL0011832936 / Valor 32590356

SIX Swiss Exchange (2026-06-05)
CHF 72.80-1.49%

COSMO Pharmaceuticals N.V.
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

COSMO Pharmaceuticals N.V. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of gastrointestinal diseases. The company has successfully brought to market six approved drugs and two medical devices, addressing unmet medical needs in this therapeutic area. COSMO Pharmaceuticals is involved in the entire product lifecycle, from identifying medical needs and managing product development to obtaining regulatory approvals. The company licenses its approved products to partners with strong marketing and sales capabilities, ensuring effective market penetration. Additionally, COSMO offers a range of services related to pharmaceutical production, including the assessment of manufacturing processes, technology transfer, evaluation of product stability, market testing and release, and the preparation of necessary documentation for product registration.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

23.2%1Y
53.9%3Y
-15.1%5Y

Performance

46.1%1Y
37.1%3Y
35.3%5Y

Volatility

Market cap

1480 M

Market cap (USD)

Daily traded volume (Shares)

15,383

Daily traded volume (Shares)

1 day high/low

63.8 / 61.5

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
3.50
Innovation:
starstarstarstarstar
4.50
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Andrei Khristoliubov
United Kingdom, 21 Feb 2026
star star star star star
.
Matthew Waterhouse
United Kingdom, 19 Feb 2026
star star star star star
.

EQUITIES OF THE SAME SECTOR

Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.19%USD 20.51
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.19%USD 486.98
Ensign Group Inc
Ensign Group Inc Ensign Group Inc Valor: 3109721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.66%USD 170.30
Sotera Health Company
Sotera Health Company Sotera Health Company Valor: 57897071
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.32%USD 15.62
Alkermes PLC
Alkermes PLC Alkermes PLC Valor: 13920929
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.34%USD 42.80
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.08%USD 19.52
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.00%CHF 0.91
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.85%CHF 117.98
Surgery Partners Inc
Surgery Partners Inc Surgery Partners Inc Valor: 29308003
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%USD 13.71
Olaplex Holdings Inc
Olaplex Holdings Inc Olaplex Holdings Inc Valor: 113471584
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 2.04